Elevated Serum Levels of MCP-1 and IP-10 Chemokines in Patients with COVID-19 Infection
NeuroQuantology
; 20(6):6769-6779, 2022.
Article
in English
| EMBASE | ID: covidwho-1939461
ABSTRACT
Background:
There are little researches taken discussed the effect of IP-10 and MCP-1 in the coronavirus infection. Therefore, our study mainly aims to estimate whether IP-10 and MCP-1 is associated to disease severity in a samples of Iraqi patients with COVID-19.Methods:
The Cross-sectional study included 90 patients infected with covid-19 virus divided in to (45) with severe infection and (45) with mild infection,51 males and 39 females. Serum levels of MCP-1 and IP-10 was measured by sandwich ELISA test.Results:
MCP-1 chemokine in severe COVID-19 patients was significantly higher (P=0.000) than in mild patients. Also, IP-10 chemokine showing a higher significant association (P =0.025) with severe patients group. There is a highly significant difference of Oxygen saturation in the distribution of mild and severe patients (P= 0.000). The Computed Tomography, Ferritin and D.dimer showing a higher significant association with severe patients (P=0.000) compared with mild patients.Conclusion:
According to the current study the serum levels of Interferon Gamma Induced Protein 10 (IP-10) and Monocyte Chemotactic Protein 1 (MCP-1) showing a significant association with the severe COVID-19 infections.
adult; article; computer assisted tomography; controlled study; coronavirus disease 2019; cross-sectional study; female; gene expression; human; human tissue; Iraqi; major clinical study; male; nonhuman; oxygen saturation; protein blood level; protein expression; sandwich ELISA; Severe acute respiratory syndrome coronavirus 2; chemokine; D dimer; endogenous compound; ferritin; gamma interferon inducible protein 10; monocyte chemotactic protein 1
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
NeuroQuantology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS